These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 3897107)

  • 1. [Branched-chain amino acids and their ketoanalogs: therapeutic uses in patients with chronic liver or kidney failure].
    Bode JC
    Internist (Berl); 1985 Jul; 26(7):388-98. PubMed ID: 3897107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic significance of branched-chain keto and amino acids].
    Schauder P
    Internist (Berl); 1984 May; 25(5):313-9. PubMed ID: 6376411
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Amino acid precursors in nitrogen-accumulation diseases.
    Bhagavan NV
    N Engl J Med; 1975 Aug; 293(8):408. PubMed ID: 1152944
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic aspects of branched-chain amino and keto acids.
    Walser M
    Clin Sci (Lond); 1984 Jan; 66(1):1-15. PubMed ID: 6360490
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral administration of branched-chain amino acids in the treatment of hepatic disease].
    Qian SC
    Zhonghua Yi Xue Za Zhi; 1986 Sep; 66(9):525-7, 574. PubMed ID: 3098373
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of keto analogues of essential amino acids in portal-systemic encephalopathy.
    Maddrey WC; Weber FL; Coulter AW; Chura CM; Chapanis NP; Walser M
    Gastroenterology; 1976 Aug; 71(2):190-5. PubMed ID: 939376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy].
    Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
    Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.
    Ndraha S; Hasan I; Simadibrata M
    Acta Med Indones; 2011 Jan; 43(1):18-22. PubMed ID: 21339541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Branched-chain amino acids and their therapeutic use].
    Internist (Berl); 1992 Dec; (12 Suppl):1-8. PubMed ID: 7591602
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hepatic encephalopathy with oral branched-chain amino acids: I. Acute hepatic encephalopathy].
    Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
    Rev Esp Enferm Apar Dig; 1987 Aug; 72(2):116-22. PubMed ID: 3659529
    [No Abstract]   [Full Text] [Related]  

  • 11. [Branched-chain amino acids for patients with liver disease--an effective treatment or scientific humbug?].
    Eriksson LS; Wahren J
    Lakartidningen; 1984 Feb; 81(9):774-6. PubMed ID: 6708678
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale and indications for the use of alpha-keto analogues.
    Walser M
    JPEN J Parenter Enteral Nutr; 1984; 8(1):37-41. PubMed ID: 6366288
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study.
    Walker S; Götz R; Czygan P; Stiehl A; Lanzinger G; Sieg A; Raedsch R; Kommerell B
    Digestion; 1982; 24(2):105-11. PubMed ID: 7128954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a keto acid-amino acid supplement on the metabolism and renal elimination of branched-chain amino acids in patients with chronic renal insufficiency on a low protein diet.
    Teplan V; Schück O; Horácková M; Skibová J; Holecek M
    Wien Klin Wochenschr; 2000 Oct; 112(20):876-81. PubMed ID: 11244613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dietary protein contribution and hepatic encephalopathy in cirrhosis].
    Zavaglia C; Brivio M; Losacco E; Onida L
    Recenti Prog Med; 1992 Apr; 83(4):218-23. PubMed ID: 1626117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keto-analogues of essential amino acids in the treatment of chronic renal failure.
    Walser M
    Kidney Int Suppl; 1978 Jun; (8):S180-4. PubMed ID: 278888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of keto analogs of essential amino acids (EAS) on the plasma amino acid picture in chronic kidney failure].
    Meisinger E; Zimmerman E; Schubert I; Strauch M
    Med Welt; 1980 Jun; 31(26):1000-3. PubMed ID: 7421528
    [No Abstract]   [Full Text] [Related]  

  • 18. Branched-chain amino acids in chronic liver failure: good friends or hated enemies?
    Rossi Fanelli F; Cangiano C
    Nutrition; 1990; 6(5):414-5. PubMed ID: 2134568
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of endocrine changes and of hypertension in the progression of diabetic renal failure in patients following a low protein diet supplemented with essential amino acids and keto-analogues.
    Ciardella F; Barsotti G; Niosi F; Morelli E; Petronio MG; Mazzotta L; Mantovanelli A; Caprioli R; Mosaico A; Giovannetti S
    Scand J Urol Nephrol Suppl; 1988; 108():41-6. PubMed ID: 3163830
    [No Abstract]   [Full Text] [Related]  

  • 20. Amino acids in hepatic encephalopathy.
    James JH; Freund H; Fischer JE
    Gastroenterology; 1979 Aug; 77(2):421-3. PubMed ID: 109349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.